Canopy Growth Corporation (CGC) vs Siga Technologies Inc. (SIGA)

Canopy Growth Corporation and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $311.2M against $229.2M — 1.4× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −80.4%) and the higher return on invested capital (−14.6% vs −17.2%). Across the 19 metrics below, Siga Technologies Inc. leads on 12 and Canopy Growth Corporation on 7.

Valuation

Metric CGC SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.41 4.24 2.11
P/B 0.60 1.38 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 1.07 5.01 2.73
Earnings yield (62.58%) (1.26%) (4.38%)
Free cash flow yield (20.24%) (9.02%) 0.00%

Profitability

Metric CGC SIGA Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 54.35% 53.94%
Operating margin (54.89%) (20.76%) 0.00%
Net margin (80.39%) (5.19%) 0.00%
Free cash flow margin (28.34%) (37.58%) 0.00%
Return on equity (40.14%) (1.49%) (0.40%)
Return on assets (23.54%) (1.36%) (3.32%)
Return on invested capital (17.19%) (14.59%) 0.00%

Growth

Metric CGC SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% (70.13%) 10.01%
EPS growth (last fiscal year) 84.00% (60.98%) 49.06%
Revenue growth, 5-year CAGR (13.04%) (5.42%) 6.74%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric CGC SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 0.00 0.05
Current ratio 3.04 21.72 2.31
Net debt to EBITDA 1.09 (6.39) 0.97

Dividend

Metric CGC SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.57%
Payout ratio — — 0.27

Size

Metric CGC SIGA Drug Manufacturers Specialty & Generic median
Market cap 311.15m 229.20m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack